TrialSite News continues its series on offering a preliminary overview of clinical research sites worldwide. Clinical Trials of Texas, Inc., one of the eight different independent research site companies that have come together under the hyperCORE network umbrella, focuses on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors/CROs. 

It’s important that the participants of all clinical trials feel safe and cared for in their quest for recovery and wellbeing. For any that have been referred to a clinical trial, TrialSite News believes that you deserve to know as much relevant information as possible when it comes to making informed decisions about your healthcare. 

Clinical Trials of Texas

As reported on the hyperCORE website, “Clinical Trials of Texas, Inc. (CTT) was founded in 2001 to conduct pharmaceutical and device research studies with high integrity and exceptional quality realized through an outstanding group of research professionals and investigators affiliated with CTT. CTT has a highly-equipped and versatile 19,000 sq. ft. facility capable of conducting Early Phase – Phase IV studies in a multitude of therapeutic areas. CTT works with 10 board-certified physicians to conduct studies in their respective medical specialties. This network of investigators has helped create one of the largest and most capable stand-alone research sites in the United States.” For more information, we invite you to visit http://SAresearch.com.

Clinical Trials of Texas, INC. (CTT) positions be “a top-quality multi-specialty research organization.” Their history: Kay Scroggins, RN, CCRC, founded Clinical Trials of Texas, Inc. (CTT) in 2001. She has been in the clinical research industry for more than 20 years. Kay was honored in 2015 by the San Antonio Business Journal with a “C-Suite Award for Small/Midsize Companies.” She also was honored as a “2018 Woman Business Owner of the Year.” Kay’s vision to successfully conduct pharmaceutical and device research studies with high integrity and exceptional quality is realized today through the outstanding group of research professionals and investigators affiliated with CTT.

CTT has a highly-equipped and versatile 19,000 sq. ft. facility capable of conducting Early Phase – Phase IV studies in a multitude of therapeutic areas. Their Medical Director, Douglas Denham, DO, CPI along with 16 other board-certified physicians, who practice in the San Antonio area, work with CTT to conduct studies in their respective medical specialties. This network of investigators has helped create one of the largest and most capable research sites in the United States. The top priorities of CTT can be quickly understood by simply reading their Mission & Vision Statement.

About the hyperCORE 

The hyperCORE clinical research network was covered by TrialSite News back in April 2019. A “Super Network” of highly awarded and experienced Clinical Research Site Organizations, it forms “the second largest site network in the world with more than 80 sites across 5 countries on 2 continents,” according to their recent press release. 

Key Investigators

For more information on the key investigators at Clinical Trials of Texas, Inc., we invite you to see the links below. TrialSite News researchers appreciated the thorough amount of information on their website, and we invite all those interested to learn more here

Douglas Denham, DO, CPI, Chief Medical Director

Ayo Avworo DNP, APRN, FNP-BC, Investigator

Thomas R. Weiss, MD Principal Investigator

Kerry De Jesus, Psy.D, Investigator/Rater, Mental Health

Parke J. Hedges, MD, Principal Investigator

Jason Miller, DO, Principal Investigator

Terri Nutt, MD, Principal Investigator

Camilo A. Gonima, MD, Principal Investigator

Bryan M. Cox, MD, Principal Investigator

Pendleton Wickersham, MD, Principal Investigator

Scott M. Henslee, MD, Principal Investigator

Jose M. Ruiz, III, MD, Principal Investigator

Lisa Martén, MD, Principal Investigator

Martha Leatherman, MD, Principal Investigator

Valentin Almendarez, Jr., MD, Principal Investigator

Elizabeth Hughes Tichy, MD, Principal Investigator

Boulos Toursarkissian, MD, Principal Investigator

Damaso Oliva, Jr., MD, Investigator

Research Sites of CTT

CTT has many studies and invites those interested to “participate in a clinical trial in San Antonio, TX to learn more about your condition, advance medical research, and receive access to new treatments and medications at no cost to you! Compensation is often available. It’s easy, just browse currently enrolling studies and apply online to see if you qualify.” 

Currently enrolling studies include: 

ADHD – With Aggression – Teen, Anxiety – Upcoming Studies, Arthritis of the Knee, Asthma – Pediatric, Cardiovascular – Upcoming Studies, Critical Limb Ischemia (CLI), Depression – Adult – On Medication, Depression – Child, Depression – Current Antidepressant Not Working, Depression – Not on Meds, Depression Consultation, Diabetes – Type 1, Diabetes – Type 1 and 2, Diabetes – Type 1 on Short and Long Acting Insulin, Diabetic Gastroparesis, Diabetic Retinopathy, Fatty Liver – NAFLD and Type 2 Diabetes, Fatty Liver – NASH, Free Screening: Diabetes, Free Screening: Fatty Liver, Free Screening: Memory Loss, Healthy Volunteers, Healthy Volunteers – Ages 18-65, Healthy Volunteers – Upcoming Studies, Hot Flashes, Irritable Bowel Syndrome, Memory Loss/Mild Cognitive Impairment, Migraines, Ophthalmology – Upcoming Studies, PTSD, Pain Management/Anesthesiology – Upcoming Studies, Psoriasis – Ages 12+, Rheumatoid Arthritis – Currently on Medication, Schizophrenia, Uterine Fibroids, Vaccine – Pneumonia, and Vascular Medicine/Surgery – Upcoming Studies.

FDA Findings

Upon initial inspection, TrialSite researchers did not find any significant FDA Inspections or Warning Letters. This suggests they are complainant with all current regulations. Should CTT have any future interactions with the FDA, we will update as necessary. 

Their Google Listing shows reviewers have granted them a fairly high rating of 3.5 stars. You can see their LinkedIn page, Yelp page, and Facebook page for more information. With all their social media accounts set up and running, and the good amount of reviews they have, we are impressed. This suggests that they care about their patients having an online platform to share their opinions, allowing CTT the option to better their care. 

Call to Action: To see our future coverage of hyperCORE’s research network, we invite you to sign up for our Daily Digest. If you would like an introduction to Clinical Trials of Texas, Inc, TrialSite News can help. 

Source:

Pin It on Pinterest